Nat Rev Endocrinol 8(12):728742 Davies MJ, Bain SC, Atkin SL, Rossing P, Scott D, Shamkhalova MS et al (2015) Efficacy and safety of liraglutide versus placebo as add-on to glucose-lowering therapy in patients with type 2 diabetes and moderate renal impairment (LIRA-RENAL): a randomized clinical trial
They were first used for diabetes, and newer research shows benefits for heart and kidney protection in selected patients too
However, these medications, including Ozempic and Zepbound, arent for everyone and can be pretty expensive, especially if you have to pay for them out of pocket
You can inject cold medication
Comparative Effectiveness of Glucagon-Like Peptide-1 Receptor Agonists Sodium/Glucose Cotransporter 2 Inhibitors in Preventing Chronic Kidney Failure Mortality in Patients with Type 2 Diabetes, CKD
While convenient, this means you're self-selecting without professional guidance